1.A Case of Aortic Valve Replacement with Valve Ring Enlargement for Future TAV in SAV
Mitsukuni NAKAHARA ; Kenji IINO ; Yoshitaka YAMAMOTO ; Masaki KITAZAWA ; Hiroki NAKABORI ; Hideyasu UEDA ; Yukiko YAMADA ; Akira MURATA ; Hirofumi TAKEMURA
Japanese Journal of Cardiovascular Surgery 2024;53(3):114-118
When performing aortic valve replacement in young patients, mechanical valves are recommended due to their durability. However, because mechanical valves require lifelong use of warfarin and carry risks such as easy bleeding, bioprosthetic valve replacement may be performed in some cases even in young patients. In this report, we describe a case of a patient who underwent bioprosthetic aortic valve replacement with aortic annular enlargement in anticipation of TAV in SAV and had a good postoperative course. The patient is a 51-year-old male. He was referred to our hospital for surgical treatment of severe aortic stenosis. The patient strongly preferred a bioprosthetic valve due to the disadvantage of taking warfarin. Therefore, we considered the possibility of TAV in SAV due to his young age, and decided to perform aortic annular enlargement if necessary. Intraoperatively, after resection and decalcification of the valve, a sizer was inserted, but the 19 mm sizer could not pass through, so we decided to perform aortic annular enlargement. Aortic annular enlargement was performed by suturing a Dacron patch and implantation of a 23 mm bioprosthetic valve. The patient had no major postoperative problems and was discharged home on the 14th day after surgery. In order to avoid PPM in the future when TAVI is performed, aortic annular enlargement should be considered in young patients undergoing aortic valve replacement using a bioprosthetic valve if TAV in SAV is considered to be difficult.
2.Analysis of Risk Factors for Ganciclovir-Induced Thrombocytopenia and Construction of Risk-Prediction Models Using a Decision Tree Analysis
Shungo IMAI ; Takehiro YAMADA ; Kumiko KASASHI ; Masaki KOBAYASHI ; Ken ISEKI
Japanese Journal of Drug Informatics 2019;21(1):9-19
Objective: Hematological toxicity, including neutropenia and thrombocytopenia, is a typical side effect of ganciclovir (GCV). We previously developed a risk-prediction model for GCV-induced neutropenia using decision tree (DT) analysis. By employing the DT model, which is a flowchart-like framework, users can predict the combination of factors that may increase neutropenia risk. However, a risk-prediction model for thrombocytopenia has not been established. Here, we aimed to identify the risk factors associated with GCV-induced thrombocytopenia and construct risk-prediction models.Method: We retrospectively evaluated the medical records of 386 patients who received GCV between April 2008 and March 2018 at Hokkaido University Hospital. Thrombocytopenia is defined as a decrease in the platelet count (PLT) to <50,000 cells/mm3 and to a <75% decrease. Risk factors of thrombocytopenia were extracted from the medical records using a multiple logistic regression analysis. Moreover, we employed chi-squared automatic interaction detection (CHAID) and classification and regression tree (CRT) algorithms to develop the DT models. The accuracies of the established models were evaluated to assess their reliability.Results: Thrombocytopenia occurred in 47 (12.2%) patients. In the multiple logistic regression analysis, data of patients with white blood cells <7,000 cells/mm3,PLT<101,000 cells/mm3 and total bilirubin ≥ 0.8 mg/dL were extracted. Two risk-prediction models were constructed, and patients were divided into six and seven subgroups. In both algorithms, data on hematopoietic stem cell transplantations, PLT <101,000 cells/mm3, serum albumin < 2.8 g/dL, total bilirubin ≥ 0.8 mg/dL, and residence in intensive care unit were extracted. The predictive accuracy of both the CHAID algorithm and the logistic regression models was 87.8% and that of the CRT algorithm was 88.3%, indicating they were reliable.Conclusion: We successfully identified the factors associated with GCV-induced thrombocytopenia and constructed useful flowchartlike risk-prediction models.
3.Regional Differences in the Safety of Telaprevir-Based Triple Therapy for Chronic Hepatitis C in Japan:
Ryo IKETANI ; Kazuki IDE ; Hiroshi YAMADA ; Yohei KAWASAKI ; Naohiko MASAKI
Japanese Journal of Drug Informatics 2018;20(2):57-65
Objective:The objectives were to assess regional differences in the safety outcomes of telaprevir-based triple therapy(T/PR) in Japan and evaluate a suitable generalized linear mixed model for estimating regional differences.Design and Methods:This study targeted individuals infected with genotype 1 chronic hepatitis C virus registered in a nationwide Japanese interferon database from December 2009 to August 2015. The rate of dropout from treatmentattributable to adverse events was calculated in every prefecture where ≥ 20 cases were reported. We constructed the following four models and evaluated the best-fit model based on Akaike information criterion (AIC) and Bayesian information criterion (BIC):1)prefecture as a fixed-effect,2)prefecture and identified confounding factors as fixed-effects,3)prefecture as a random-effect,and 4)prefecture as a random-effect and identified confounding factors as fixed-effects.Results:A total of 25,989 individuals from 38 prefectures were registered during the study period;among them,1,591 from18 prefectures were included as the study population. The dropout rate ranged from 7.0 to 23.1%among 17 prefectures.The model considering prefecture as a random-effect and confounding factors as fixed-effects showed the best-fit for the databased on both the AIC (1,108.06)and BIC (1,113.41).Conclusion:It is difficult to determine if regional differences exist in the safety outcomes of T/PR in Japan because of the limited number of cases. However, the model using prefecture as a random-effect and other confounding factors as fixed-effects would be suitable for estimating parameters that reflect the influence of the prefecture. Further studies using the model would help inform chronic hepatitis C treatment.
5.Study Report on Mongolian Traditional Medicine
Mitsunori SEINO ; Hideaki SHIREN ; Noriko MARUYAMA ; Haruka INOKUMA ; Toshimune NAMBA ; Takuji YOSHIDA ; Masaki YAMADA
Kampo Medicine 2017;68(3):236-244
History of Mongolian medicine could be traced back to 2000 years ago. Mongolian traditional medicine has been built over many years. We traveled Mongolia to visit a hospital and a private clinic where traditional Mongolian medicine is in practice, and visited National University of Medical Sciences. In this paper, we report the current status of traditional medicine in Mongolia. We visited Mongolian National University of Medical Sciences and conversed with the president, vicepresident, and director of the traditional medical department. We visited a clinic where Mongolian traditional medicine is performed and a hospital where mainly traditional therapies and practical development are carried out. In the hospital, they mainly provide acupuncture and moxibustion treatment, cupping therapy, herbal therapy, and thermotherapy. It cannot be denied that moxibustion treatment came from Mongolia, because it is also said that ‘the north' in “Huangdi Neijing Suwen” chapter 12 means Mongolia. However, as there is a background once traditional medicine has been kept away from the national health care system, it is difficult to find a specific medical practice for Mongolian medicine as far as we have viewed the present status of medical practice in Mongolia. Considering that the cultural exchange with Japan is being carried out in many other fields, we expect that a number of new facts will come to light in the near future.
6.Report on WFAS Houston 2014
Ikuro WAKAYAMA ; Naoto ISHIZAKI ; Munenori SAITO ; Hiroyuki TSURU ; Yoji FUKAZAWA ; Shoko MASUYAMA ; Masaki YAMADA ; Rie NISHIMURA
Journal of the Japan Society of Acupuncture and Moxibustion 2015;65(1):36-46
The WFAS Houston 2016 annual conference was held in the Royal Sonesta Hotel, Houston, Texas, USA from 31 October to 2 November 2014. The theme of the conference was "East Meets West -Shaping the Future of Healthcare", and more than 900 acupuncture practitioners and scientists participated. The number of papers presented was 216, including 6 keynote lectures. Papers from Japan numbered 11.
At the Executive Committee (EC) meeting, 39 of the 76 EC members were present (10 EC members sent a letter of attorney in advance), including 3from Japan. Although Tokyo was approved as a host city of WFAS 2016 last year, we proposed changing the venue to the Tsukuba International Congress Center, which was approved.
7.A New Electrophysiological Method for the Diagnosis of Extraforaminal Stenosis at L5-S1.
Hiroshi IWASAKI ; Munehito YOSHIDA ; Hiroshi YAMADA ; Hiroshi HASHIZUME ; Akihito MINAMIDE ; Yukihiro NAKAGAWA ; Masaki KAWAI ; Shunji TSUTSUI
Asian Spine Journal 2014;8(2):145-149
STUDY DESIGN: A retrospective study. PURPOSE: To examine the effectiveness of using an electrodiagnostic technique as a new approach in the clinical diagnosis of extraforaminal stenosis at L5-S1. OVERVIEW OF LITERATURE: We introduced a new effective approach to the diagnosis of extraforaminal stenosis at the lumbosacral junction using the existing electrophysiological evaluation technique. METHODS: A consecutive series of 124 patients with fifth lumbar radiculopathy were enrolled, comprising a group of 74 patients with spinal canal stenosis and a second group of 50 patients with extraforaminal stenosis at L5-S1. The technique involved inserting a pair of needle electrodes into the foraminal exit zone of the fifth lumbar spinal nerves, which were used to provide electrical stimulation. The compound muscle action potentials from each of the tibialis anterior muscles were recorded. RESULTS: The distal motor latency (DML) of the potentials ranged from 11.2 to 24.6 milliseconds in patients with extraforaminal stenosis. In contrast, the DML in patients with spinal canal stenosis ranged from 10.0 to 17.2 milliseconds. After comparing the DML of each of the 2 groups and at the same time comparing the differences in DML between the affected and unaffected side of each patient, we concluded there were statistically significant differences (p<0.01) between the 2 groups. Using receiver operating characteristic curve analysis, the cutoff values were calculated to be 15.2 milliseconds and 1.1 milliseconds, respectively. CONCLUSIONS: This approach using a means of DML measurement enables us to identify and localize lesions, which offers an advantage in diagnosing extraforaminal stenosis at L5-S1.
Action Potentials
;
Constriction, Pathologic*
;
Diagnosis*
;
Diagnostic Techniques and Procedures
;
Electric Stimulation
;
Electrodes
;
Humans
;
Muscles
;
Needles
;
Radiculopathy
;
Retrospective Studies
;
ROC Curve
;
Spinal Canal
;
Spinal Nerves
;
Spinal Stenosis
8.A Case of Diabetic Foot Syndrome Successfully Treated with Combination Kampo Medicine
Hiromi YANO ; Eiichi TAHARA ; Seiko YAMADA ; Toshihiko YAMAUCHI ; Ryo YOSHINAGA ; Hisashi INUTSUKA ; Masaki KUBOTA ; Michihiko HIRATA ; Kazumichi KURIYAMA ; Tadamichi MITSUMA
Kampo Medicine 2014;65(1):13-22
This case involved a 58-year-old male with diabetic foot syndrome complicated with osteomyelitis. He had been diagnosed with diabetes mellitus type 2 twenty years previously, but had ignored it and developed diabetic foot syndrome and diabetic triopathy. His HbA 1 c (NGSP) was 11.2%. Twelve days after diabetic foot onset, he was transferred to our hospital to receive Kampo medicine. His whole right leg was edematous and there were two ulcers on the dorsum (5 × 4 cm in size) and between the fourth and fifth toes (7 × 4 cm in size).We used antibiotics, insulin, and prostaglandin formulation in combination with Kampo medicine, involving hachimijioganryo because of lower abdominal numbness. Simultaneously, we used keishibukuryogan at high dosage (personalized formula, 2 g × 24 pills) for 7 days to improve blood stasis. Seven days after hospitalization, we changed the initial hachimijioganryo to hachimijiogan (personalized formula, 2.3 g × 9 pills) and kigikenchuto (astragalus root, 20 g) to accelerate ulcer granulation. We also decreased the high dose keishibukuryogan gradually. Although the bone of the DIP joint in the fifth toe was exposed, the ulcer dimensions decreased and reached 2.5 × 1.8 cm at the time of discharge (50 days after onset). Two months after onset, the ulcer had epithelialized and medical dressings were unnecessary. Four months after onset, it had completely healed. We propose that Kampo medicine is effective for diabetic foot syndrome when combined with conventional therapy, and that healing occurs earlier than with conventional therapy alone.
9.Role of interleukin-6 in orthodontically induced inflammatory root resorption in humans.
Ryuichi KUNII ; Masaru YAMAGUCHI ; Yasuhiro TANIMOTO ; Masaki ASANO ; Kunihiko YAMADA ; Takemi GOSEKI ; Kazutaka KASAI
The Korean Journal of Orthodontics 2013;43(6):294-301
OBJECTIVE: To determine the interleukin (IL)-6 levels in gingival crevicular fluid (GCF) of patients with severe root resorption after orthodontic treatment and investigate the effects of different static compressive forces (CFs) on IL-6 production by human periodontal ligament (hPDL) cells and the influence of IL-6 on osteoclastic activation from human osteoclastic precursor (hOCP) cells in vitro. METHODS: IL-6 levels in GCF samples collected from 20 patients (15 and 5 subjects without and with radiographic evidence of severe root resorption, respectively) who had undergone orthodontic treatment were measured by ELISA. The levels of IL-6 mRNA in hPDL cells and IL-6 protein in conditioned medium after the application of different uniform CFs (0, 1.0, 2.0, or 4.0 g/cm2 for up to 72 h) were measured by real-time PCR and ELISA, respectively. Finally, the influence of IL-6 on mature osteoclasts was investigated by using hOCP cells on dentin slices in a pit-formation assay. RESULTS: Clinically, the IL-6 levels were significantly higher in the resorption group than in the control group. In vitro, IL-6 mRNA expression significantly increased with increasing CF. IL-6 protein secretion also increased in a time- and magnitude-dependent manner. Resorbed areas on dentin slices were significantly greater in the recombinant human IL-6-treated group and group cultured in hPDL cell-conditioned medium with CF application (4.0 g/cm2) than in the group cultured in hPDL cell-conditioned medium without CF application. CONCLUSIONS: IL-6 may play an important role in inducing or facilitating orthodontically induced inflammatory root resorption.
Culture Media, Conditioned
;
Dentin
;
Enzyme-Linked Immunosorbent Assay
;
Gingival Crevicular Fluid
;
Humans*
;
Interleukin-6*
;
Interleukins
;
Osteoclasts
;
Periodontal Ligament
;
Real-Time Polymerase Chain Reaction
;
RNA, Messenger
;
Root Resorption*
10.Palliative care education using an e-learning system for hospital staff
Ayako Kawasaki ; Mari Saito ; Syuichi Nawata ; Yuki Iwasaki ; Azusa Kamachi ; Tomoki Yamada ; Masae Kikuchi ; Tae Urasaki ; Izumi Oene ; Mariko Kamite ; Masaki Furukawa
Medical Education 2012;43(1):27-31
1)Palliative care education by means e–learning was performed from December 3 to 25, 2009, for 1256 hospital medical staff. We used the same true–or–false questions to assess their understanding before and after the e–learning course.
2)Regardless of the staff member’s experience, the total scores on the test were higher after the course than before the course. Therefore, this e–learning course had an effect on basic knowledge for multiple types of medical staff.
3)The percentage of correct answers was particularly improved for questions about topics we had emphasized: drug dependence and side effects.


Result Analysis
Print
Save
E-mail